You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《高盛認股證牛熊證》平安好醫生衝70元 再創新高 留意少數貼價購20493
阿思達克 01-22 11:02

正股表現:平安好醫生(1833)自上週三起開始連升,今早繼續上升,最高見70.7元,繼昨日再創上市新高。現報69.9元,升約4.3%,而上週三累計至今則升約16%。有券商指平安好醫生去年下半年收入按年增長18%,並料會員制可帶動高毛利網上醫療服務,及明年業績可虧轉盈。該行維持「跑嬴大市」評級,目標價78元。

資金流向:觀察個股認股證資金流向,可見上週四至本週一皆錄得資流入,合共約300萬元。昨日則見資金轉向沽出。

產品選擇:可見大部分的產品提供的槓桿都在約3至4倍槓桿。因此投資者計劃部署認購證,可考慮選擇較貼價條款的產品。但由於股價急升,市場上價外認購證所餘無幾,可留意當中少數貼價的平醫購20493。

平醫購20493,行使價70.93元,2020年06月22日到期,實際槓桿3.2倍,市場上少數貼價認購證

註: 以上數據資料來自高盛認股證牛熊證網站~重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account